Liver transplantation following donation after cardiac death: an analysis using matched pairs

James K Pine1, Amer Aldouri, Alistair L Young

  • 1Department of Hepatobiliary/Transplant Surgery, St. James's University Hospital, Beckett Street, United Kingdom.

Insights

Grafts from donation after cardiac death (DCD) donors show higher complication rates like biliary strictures and hepatic artery stenosis compared to donation after brain death (DBD) donors. Despite poorer outcomes, DCD grafts are valuable with careful management.

Area of Science:

  • Transplantation Surgery
  • Organ Donation
  • Hepatology

Background:

  • Donation after cardiac death (DCD) liver grafts are crucial for increasing organ availability.
  • Concerns exist regarding potential graft dysfunction due to warm ischemia in DCD donors.
  • Comparing DCD and donation after brain death (DBD) outcomes is essential for optimizing liver transplantation.

Purpose of the Study:

  • To compare the outcomes of liver transplantation using DCD grafts versus DBD grafts.
  • To evaluate graft survival, primary non-function (PNF), and complication rates between DCD and DBD recipients.
  • To assess the impact of warm ischemia on DCD graft function and patient outcomes.

Main Methods:

  • A retrospective comparison of 39 DCD liver grafts with 39 case-matched DBD grafts.
  • Matching was based on variables significantly impacting mortality to ensure similar predictive risk.
  • Key outcomes analyzed included patient/graft survival, PNF, nonanastomotic biliary strictures (NABS), and hepatic artery stenosis (HAS).

Main Results:

  • DCD grafts constituted 6.1% of all liver transplants in the study period.
  • Higher incidences of NABS (20.5%) and HAS (12.8%) were observed in the DCD group compared to the DBD group (0% for both).
  • One-year (79.5% vs. 97.4%) and three-year (63.6% vs. 97.4%) graft survival, and three-year patient survival (68.2% vs. 100%) were significantly lower in the DCD group.

Conclusions:

  • DCD liver grafts are associated with significantly poorer graft and patient survival rates and increased complications like NABS and HAS.
  • NABS and HAS in DCD recipients are likely attributable to warm ischemia and potential arterial injury during retrieval.
  • Despite challenges, DCD grafts remain a valuable resource, with acceptable outcomes achievable through careful donor/recipient selection, ischemia minimization, and postoperative care.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...